肺结核患者真菌感染胸腺五肽治疗的临床疗效研究

Clinical effect of Thymopentin on treatment of fungal infections in patients with tuberculosis

  • 摘要: 目的 研究肺结核治疗过程中并发真菌感染的治疗方法及临床疗效,为提高临床治愈率提供依据。方法 选取2014年10月-2015年10月于医院诊治的120例肺结核并发真菌感染患者资料进行分析,将患者随机分为对照组和试验组,每组60例;对照组采用氟康唑或伏立康唑治疗,试验组在对照组基础上联合胸腺五肽治疗,比较两组患者临床治疗效果及动脉血气指标。结果 试验组患者治疗总有效率为93.30%,显著高于对照组的80.0%,差异有统计学意义(P<0.05);试验组患者治疗后细菌清除率为93.3%,显著高于对照组的58.3%,差异有统计学意义(P<0.05);试验组患者不良反应发生率为6.7%,显著低于对照组的15.0%,差异有统计学意义(P<0.05);两组患者治疗前动脉血气指标差异无统计学意义;试验组患者治疗后pH、SaO2以及PaO2均高于对照组,差异有统计学意义(P<0.05)。结论 肺结核患者治疗过程中并发真菌感染时,应用抗真菌药物治疗基础上联合痰热清治疗效果理想,能够提高临床疗效,药物不良反应发生率低,值得推广应用。

     

    Abstract: OBJECTIVE To explore the treatment measures for tuberculosis complicated with fungal infections and observe the clinical effects so as to raise the clinical cure rate. METHODS A total of 120 tuberculosis patients complicated with fungal infections who were treated in the hospital from Oct 2014 to Oct 2015 were enrolled in the study and randomly divided into the control group and the experimental group, with 60 cases in each group. The control group was treated with fluconazole or voriconazole, while the experimental group was given the combined Thymopentin based on the treatment of the control group. The clinical curative effects and arterial blood gas indexes were observed and compared between the two groups of patients. RESULTS The total effective rate of treatment of the experimental group was 93.30%, significantly higher than 80.0% of the control group(P<0.05). The bacterial clearance rate of the experimental group was 93.3% after the treatment, significantly higher than 58.3% of the control group (P<0.05). The incidence of adverse reactions of the experimental group was 6.7%, significantly lower than 15.0% of the control group (P<0.05). There was no significant difference in the arterial blood gas indexes between the two groups of patients before the treatment; the pH, SaO2, and PaO2 were significantly higher in the experimental group than in the control group after the treatment(P<0.05). CONCLUSION The antifungal agents combined with Tanreqing can achieve satisfied effect on treatment of the tuberculosis patients complicated with fungal infections, with the incidence of drug-induced adverse reactions low, and it is worthy to be promoted.

     

/

返回文章
返回